Michael Patrick Lux

13PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer diagnosisPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 06, 2025
Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges.

Mark Verrill, Michael Patrick Lux, Joseph Gligorov

|Sep 11, 2025
Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.

Hans-Christian Kolberg, Johannes Schumacher, Ramona Erber

|Aug 13, 2025
Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study.

Sebastian Daniel Boie, Esther Glastetter, Michael Patrick Lux

|Feb 25, 2023
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).

Maggie Banys-Paluchowski, Thorsten Kühn, Yazan Masannat

|Nov 25, 2022
PERFORM: a non-interventional study assessing the patients' treatment starting with 1L palbociclib in HR+/HER2- ABC.

Michael Patrick Lux, Eva Diana Runkel, Esther Glastetter

|Aug 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.

Ramona Erber, Miriam Angeloni, Robert Stöhr

Pageof 3

Frequent Collaborators

6 joint publications

Peter A Fasching

4 joint publications

Andreas Schneeweiss

3 joint publications

Andreas D Hartkopf

3 joint publications

Joachim Graf